1 Appendix C: Techni cal Support Documents

Additional documentation in support of this RED is maintained in the OPP docket, located in room S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive,

Arlington, VA 22202 . It is open Monday through Friday, excluding legal holidays, from 8:30 am to 4 pm.

All documents, in hard copy form, may be viewed in the OPP docket room or

downloaded or viewed via the Internet at the following site: h ttp://www.regulations.gov

These documents include:

HED Documents:

Review of the 21-day Dermal Toxicity Study. Doherty, J.; D334641; TXR 0054520; March 6, 2007.

Revised Memo to Incorporate Reponses to Phase 5 Public Comments. N-Octyl bicycloheptene dicarboximide (MGK-264): HED Chapter of the Reregistration Eligibility Decision Document (RED). Donovan, W.; D327167; March 20, 2006.

MGK-264 Indoor Handheld Fogger Applicator Scenario: Comparison of Prallethrin Inhalation Study and Florida Greenhouse Study. Weiss, S.; D327961; July 5, 2006.

MGK-264: REVISED Occupational and Re sidential Exposure Assessment for the Reregistration Eligibility Decision Docu ment. Weiss, S.; D324674; March 10, 2006.

Revised Memo to Incorporate Responses to Phase 3 Public Comments. N-Octyl bicycloheptene dicarboximide (MGK-264) RE D – Reregistration El igibility Decision. Product and Residue Chemistry Considera tions. Donovan, W.; D318874; September 9,

2005.

Review of MGK-264 Incident Reports. Blondell, J.; D306591; October 6, 2004.

N-Octyl bicycloheptene dicarboximide (MGK-264) Acute and Chronic Dietary Exposure Assessments for the Reregistration Elig ibility Decision. Donovan, W.; D295639; September 21, 2004.

MGK-264: First Report of the Hazard Identi fication Assessment Review Committee. Eiden, C.; TXR No. 0052650; June 25, 2004.

HED Response to Comments Documents:

MGK-264. Health Effects Division (HED) Ph ase 6 Response to Phase 5 Comments on the MGK-264 Preliminary Reregistration E ligibility Decision (RED) and Supporting Memos. Donovan, W., Doherty, J ., Weiss, S.; D324672; May 11, 2006.2 MGK-264. Health Effects Division (HED) Phase 4 Response to Phase 3 Public Comments on the MGK-264 Preliminary Rere gistration Eligibility Decision (RED) and Supporting Memos. Donovan, W., Doherty, J., Weiss, S.; D321193; September 15,

2005.

Piperonyl Butoxide (PBO), Pyrethrins a nd MGK-264: Health Effects Division’s response to the Registrant’s concerns for using metaplasia seen in the larynx in

subchronic inhalation studies as an endpoint for inhalation risk assessment. Ramasamy, S., et al.; D319913, D319914, and D320298; September 8, 2005.

MGK-264. HED Response to Error-Only Registrant Comments on the MGK-264 Preliminary RED. Donovan, W., Dohert y, J., Weiss, S.; D311280; March 2, 2005.

EFED Documents:

Revised Screening Ecological Risk Asse ssment for the Reregistration of MGK-264 Insecticide Synergist. Ecke l, W.; D329617; July 14, 2006.

Drinking Water Assessment for MGK-264 Ins ecticide Synergist: Surface Water Revision for Ground Spray. Eckel, W.; D305104; February 17, 2005.

EFED Response to Comments Documents:

Response to Comments of Phase 5 Period A bout Water Quality, and Other Issues on the Revised Draft EFED RED Chapters for Pyre thrins, PBO and MGK-264. Davy, M., et al.; D324663, D324664, D324667, D324662, D324671, and D324673; January 30, 2006.

Response to Pubic Comments on Drinking Water Assessment for MGK-264 Insecticide Synergist. Eckel, W.; D318870; August 31, 2005.

Response to Public Comments on Ecologica l Risk Assessment for MGK-264 Insecticide Synergist. Eckel, W., and Lee, R.; D318871; August 31, 2005.

Response to Error-Only Review of Ecologi cal Risk Assessment and Drinking Water Assessment for MGK-264 Insecticide Synergist. Eckel, W.; D295633; February 17,

2005.